NO983776L - 1,4-Dihydropyridin-forbindelser som Bradykinin-antagonister - Google Patents

1,4-Dihydropyridin-forbindelser som Bradykinin-antagonister

Info

Publication number: NO983776L
Authority: NO; Norway
Prior art keywords: bradykinin; octyl; alkyl; dihydropyridine compounds; bradykinin antagonists
Prior art date: 1996-02-19

Application number

NO983776A

Other languages

English (en)

Norwegian (no)

Other versions

NO983776D0 (no

Inventor

Takafumi Ikeda

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-02-19

Filing date

1998-08-18

Publication date

1998-08-18

1998-08-18 Application filed by Pfizer filed Critical Pfizer

1998-08-18 Publication of NO983776D0 publication Critical patent/NO983776D0/no

1998-08-18 Publication of NO983776L publication Critical patent/NO983776L/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Oncology (AREA)
Hospice & Palliative Care (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Dermatology (AREA)
Otolaryngology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Hydrogenated Pyridines (AREA)
Pyridine Compounds (AREA)

NO983776A 1996-02-19 1998-08-18 1,4-Dihydropyridin-forbindelser som Bradykinin-antagonister NO983776L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IB9600132		1996-02-19
PCT/IB1997/000058 WO1997030048A1 (fr)	1996-02-19	1997-01-27	Composes de 1,4-dihydropyridine utilises comme antagonistes de la bradykinine

Publications (2)

Publication Number	Publication Date
NO983776D0 NO983776D0 (no)	1998-08-18
NO983776L true NO983776L (no)	1998-08-18

Family

ID=11004406

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO983776A NO983776L (no)	1996-02-19	1998-08-18	1,4-Dihydropyridin-forbindelser som Bradykinin-antagonister

Country Status (34)

Country	Link
US (1)	US6131226A (fr)
EP (1)	EP0882044B1 (fr)
JP (1)	JP3167335B2 (fr)
KR (1)	KR19990082678A (fr)
CN (1)	CN1211251A (fr)
AR (1)	AR005841A1 (fr)
AT (1)	ATE220676T1 (fr)
AU (1)	AU1396497A (fr)
BG (1)	BG102678A (fr)
BR (1)	BR9707568A (fr)
CA (1)	CA2245857C (fr)
CO (1)	CO4650041A1 (fr)
CZ (1)	CZ258698A3 (fr)
DE (1)	DE69714019T2 (fr)
DK (1)	DK0882044T3 (fr)
ES (1)	ES2177921T3 (fr)
HN (1)	HN1997000013A (fr)
HR (1)	HRP970094A2 (fr)
HU (1)	HUP9902810A3 (fr)
ID (1)	ID16434A (fr)
IL (1)	IL124867A0 (fr)
IS (1)	IS4783A (fr)
MA (1)	MA26419A1 (fr)
NO (1)	NO983776L (fr)
NZ (1)	NZ325455A (fr)
OA (1)	OA10712A (fr)
PE (1)	PE36298A1 (fr)
PL (1)	PL328514A1 (fr)
PT (1)	PT882044E (fr)
SI (1)	SI0882044T1 (fr)
TN (1)	TNSN97037A1 (fr)
TR (1)	TR199801593T2 (fr)
WO (1)	WO1997030048A1 (fr)
ZA (1)	ZA971357B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH11106375A (ja) *	1997-08-18	1999-04-20	Pfizer Pharmaceut Inc	ブラジキニンアンタゴニストとしての光学的に活性な１，４−ジヒドロピリジン化合物
EP1110962A1 (fr) *	1999-12-10	2001-06-27	Pfizer Inc.	Procede pour la preparation de composes 1,4-dihydropyridines
US6653313B2 (en) *	2000-08-10	2003-11-25	Warner-Lambert Company Llc	1,4-dihydropyridine compounds as bradykinin antagonists
GB0427281D0 (en) *	2004-12-14	2005-01-12	3M Innovative Properties Co	Methods of providing medicinal metal components having through holes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5120750A (en) *	1989-01-17	1992-06-09	Synphar Laboratories, Inc.	Generation of 1,4-dihydropyridine derivatives
WO1996006083A1 (fr) *	1994-08-24	1996-02-29	Pfizer Pharmaceuticals Inc.	2-(piperazinyl-1-carbonylmethyl)-1,4-dihydropyridines utilisees comme antagonistes de bradykinine
MX9701245A (es) *	1996-02-19	1998-04-30	Pfizer	Compuestos de 1,4 dihidropiridina.

1996
- 1996-02-18 TN TNTNSN97037A patent/TNSN97037A1/fr unknown
1997
- 1997-01-27 CN CN97192240A patent/CN1211251A/zh active Pending
- 1997-01-27 SI SI9730361T patent/SI0882044T1/xx unknown
- 1997-01-27 HU HU9902810A patent/HUP9902810A3/hu unknown
- 1997-01-27 EP EP97900401A patent/EP0882044B1/fr not_active Expired - Lifetime
- 1997-01-27 TR TR1998/01593T patent/TR199801593T2/xx unknown
- 1997-01-27 CA CA002245857A patent/CA2245857C/fr not_active Expired - Fee Related
- 1997-01-27 WO PCT/IB1997/000058 patent/WO1997030048A1/fr not_active Ceased
- 1997-01-27 KR KR1019980706424A patent/KR19990082678A/ko not_active Ceased
- 1997-01-27 NZ NZ325455A patent/NZ325455A/xx unknown
- 1997-01-27 IL IL12486797A patent/IL124867A0/xx unknown
- 1997-01-27 BR BR9707568A patent/BR9707568A/pt active Search and Examination
- 1997-01-27 JP JP52913897A patent/JP3167335B2/ja not_active Expired - Fee Related
- 1997-01-27 DE DE69714019T patent/DE69714019T2/de not_active Expired - Fee Related
- 1997-01-27 PL PL97328514A patent/PL328514A1/xx unknown
- 1997-01-27 ES ES97900401T patent/ES2177921T3/es not_active Expired - Lifetime
- 1997-01-27 PT PT97900401T patent/PT882044E/pt unknown
- 1997-01-27 US US09/125,137 patent/US6131226A/en not_active Expired - Fee Related
- 1997-01-27 HN HN1997000013A patent/HN1997000013A/es unknown
- 1997-01-27 AT AT97900401T patent/ATE220676T1/de not_active IP Right Cessation
- 1997-01-27 AU AU13964/97A patent/AU1396497A/en not_active Abandoned
- 1997-01-27 DK DK97900401T patent/DK0882044T3/da active
- 1997-01-27 CZ CZ982586A patent/CZ258698A3/cs unknown
- 1997-02-10 PE PE1997000085A patent/PE36298A1/es not_active Application Discontinuation
- 1997-02-13 CO CO97007547A patent/CO4650041A1/es unknown
- 1997-02-17 AR ARP970100614A patent/AR005841A1/es unknown
- 1997-02-18 HR HRPCT/IB96/00132A patent/HRP970094A2/xx not_active Application Discontinuation
- 1997-02-18 ZA ZA971357A patent/ZA971357B/xx unknown
- 1997-02-18 ID IDP970467A patent/ID16434A/id unknown
- 1997-02-18 MA MA24498A patent/MA26419A1/fr unknown
1998
- 1998-06-25 IS IS4783A patent/IS4783A/is unknown
- 1998-07-10 OA OA9800111A patent/OA10712A/en unknown
- 1998-08-10 BG BG102678A patent/BG102678A/xx unknown
- 1998-08-18 NO NO983776A patent/NO983776L/no unknown

Also Published As

Publication number	Publication date
ZA971357B (en)	1998-08-18
KR19990082678A (ko)	1999-11-25
EP0882044B1 (fr)	2002-07-17
CZ258698A3 (cs)	1999-06-16
IS4783A (is)	1998-06-25
WO1997030048A1 (fr)	1997-08-21
OA10712A (en)	2001-06-04
HN1997000013A (es)	1997-06-26
TNSN97037A1 (fr)	2005-03-15
BR9707568A (pt)	1999-07-27
DK0882044T3 (da)	2002-09-02
BG102678A (en)	1999-04-30
JP3167335B2 (ja)	2001-05-21
EP0882044A1 (fr)	1998-12-09
PL328514A1 (en)	1999-02-01
PE36298A1 (es)	1998-07-18
SI0882044T1 (en)	2002-10-31
ATE220676T1 (de)	2002-08-15
PT882044E (pt)	2002-11-29
CO4650041A1 (es)	1998-09-03
JPH11507949A (ja)	1999-07-13
HUP9902810A2 (hu)	2000-05-28
IL124867A0 (en)	1999-01-26
ES2177921T3 (es)	2002-12-16
HRP970094A2 (en)	1998-06-30
ID16434A (id)	1997-09-25
NO983776D0 (no)	1998-08-18
CA2245857A1 (fr)	1997-08-21
CN1211251A (zh)	1999-03-17
AR005841A1 (es)	1999-07-14
HUP9902810A3 (en)	2000-09-28
MA26419A1 (fr)	2004-12-20
DE69714019D1 (de)	2002-08-22
DE69714019T2 (de)	2002-11-14
TR199801593T2 (xx)	1999-12-21
NZ325455A (en)	1999-07-29
US6131226A (en)	2000-10-17
AU1396497A (en)	1997-09-02
CA2245857C (fr)	2002-10-01

Publication	Publication Date	Title
TR199801642T2 (xx)	1998-11-23	Tedavide faydal� olan karbamik asitlerin azabisiklik esterleri.
NO990551L (no)	1999-04-07	Piperidin- og piperazinderivater, og deres anvendelse som muskarine antagonister
NO20050417L (no)	2005-02-17	Azaindol kinase-inhibitorer
EP0948327A4 (fr)	2003-04-02	Agents antidiabetiques
NO882036D0 (no)	1988-05-10	Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske ketoner.
NO971471L (no)	1997-05-30	Nye karboksamider med fungicid aktivitet
NO960393L (no)	1996-07-09	Heterosykliske fenylforbindelser som COX-2-inhibitorer
NO175309C (no)	1994-09-28	Analogifremgangsmåte for fremstilling av nye, terapeutisk virksomme tricykliske, nitrogenholdige forbindelser
BG100692A (en)	1997-09-30	New heterocyclic compounds
BR0211119A (pt)	2005-12-13	Composto, método de tratar um paciente que tenha, ou de prevenir um paciente de pegar, uma doença ou condição, uso de um composto, e, método para fabricar um composto
PT863875E (pt)	2003-10-31	Novos compostos 4-(oxialcoxifenil)-3-oxi-piperidina para o tratamento de insuficiencia cardiaca e renal
NO20032801L (no)	2003-08-04	Tiazolderivater for behandling av PPAR-relaterte forstyrrelser
CA2449402A1 (fr)	2002-12-12	Tetrahydroisoquinolines substituees destinees au traitement des maladies inflammatoires
DE69108048D1 (de)	1995-04-13	Derivate von hydroxaminsäure und von n-hydroxyharnstoff sowie ihre verwendung.
NO913923L (no)	1991-12-06	17beta-substituerte-4-aza-5alfa-androstan-3-on-derivater ogfremgangsmaate ved fremstilling av disse
TR200000671T2 (tr)	2000-07-21	FP agonistleri olarak yararlı aromatik C16-C20-ikameli tetrahidro prostaglandinler.
DE602004016123D1 (de)	2008-10-09	Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
ES2087038A1 (es)	1996-07-01	Nuevas piperidinas con actividad antagonista del paf.
NO983992L (no)	1998-10-30	Serinprotease inhibitorer
NO20032261L (no)	2003-07-09	Medisinske preparater
DE69814979D1 (de)	2003-07-03	Blutlipoproteinspiegel regulierendes Präparat
ES2029801T3 (es)	1992-10-01	Procedimiento para preparar acidos tetrahidro-3-piridina-carboxilicos sustituidos y esteres y amidas de los mismos con actividad colinergica.
NO972887L (no)	1997-08-20	Piperidineddiksyrederivater anvendelige som fibrinogen-antagonistmiddel
DE69707372D1 (de)	2001-11-22	Verwendung eines Phosphorsäurediesters zur Herstellung eines Arzneimittels zur Behandlung von Akne
DE69501359D1 (de)	1998-02-12	Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina